Journal of Clinical and Experimental Hematopathology · 2017 · 27 citations · 23 references
MedicineHematologyOncologyCancer GeneticsHematologic OncologyMolecular OncologyHematologic MalignanciesHematologic PathologyHematopoietic NeoplasmsLymphocyte DevelopmentLymphoid NeoplasmsLymphoid TumorsB LymphopoiesisFrameshift MutationsLymphoma Genetic AbnormalitiesLymphoma Pathogenesis
Ten-eleven translocation-2 (TET2) mutation is frequently observed in myeloid malignancies, and loss-of-function of TET2 is essential for the initiation of malignant hematopoiesis. TET2 mutation presents across disease entities and was reported in lymphoid malignancies. We investigated TET2 mutations in 27 diffuse large B-cell lymphoma (DLBCL) patients and found a frameshift mutation in 1 case (3.7%). TET2 mutation occurred in some populations of DLBCL patients and was likely involved in the pathogenesis of their malignancies.
23
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
Ash A. Alizadeh, Michael B. Eisen, R. Eric Davis et al. · Nature · 2000 · 10K citations
Mutation in <i>TET2</i> in Myeloid Cancers
François Delhommeau, Sabrina Dupont, Véronique Della Valle et al. · New England Journal of Medicine · 2009 · 1.7K citations · Full text
Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma
Ryan D. Morin, María Méndez-Lago, Andrew J. Mungall et al. · Nature · 2011 · 1.6K citations · Full text
Oncogenically active MYD88 mutations in human lymphoma
Vu N. Ngo, Ryan M. Young, Roland Schmitz et al. · Nature · 2010 · 1.5K citations · Full text
Tet2 Loss Leads to Increased Hematopoietic Stem Cell Self-Renewal and Myeloid Transformation
Kelly Moran-Crusio, Linsey B. Reavie, Alan H. Shih et al. · Cancer Cell · 2011 · 1.3K citations · Full text